Klacid 250mg 14 Tablets

Active Ingredient: Clarithromycin Bronchitis, acute bacterial exacerbation: Treatment of acute bacterial exacerbation of chronic bronchitis in adults due to susceptible Haemophilus influenzae, H. parainfluenzae, Moraxella catarrhalis, or Streptococcus pneumoniae. Helicobacter pylori eradication: Eradication of Helicobacter pylori to reduce the risk of duodenal ulcer recurrence as a component of combination therapy (triple therapy) in adults with H. pylori infection and duodenal ulcer disease (active or 5 year history of duodenal ulcer). Limitations of use: Regimens that contain clarithromycin as the single antibacterial agent are more likely to be associated with the development of clarithromycin resistance. Clarithromycin-containing regimens should not be used in patients with known or suspected clarithromycin-resistant isolates (efficacy is reduced). Mycobacterial infections, disseminated: Prophylaxis and treatment of disseminated mycobacterial infections due to Mycobacterium avium complex (MAC) in patients with advanced HIV infection. Otitis media: Treatment of acute otitis media in pediatric patients due to susceptible H. influenzae, M. catarrhalis, or S. pneumoniae. Pharyngitis/tonsillitis: Treatment of pharyngitis/tonsillitis due to susceptible Streptococcus pyogenes (alternative agent). Pneumonia, community-acquired: Treatment of community-acquired pneumonia due to susceptible Mycoplasma pneumoniae, S. pneumoniae, or Chlamydophila pneumoniae (adult and pediatric patients) and H. influenzae, H. parainfluenzae, or M. catarrhalis (adults). Sinusitis: Treatment of acute maxillary sinusitis due to susceptible H. influenzae, S. pneumoniae, or M. catarrhalis. Skin/skin structure infections: Treatment of uncomplicated skin/skin structure infection due to susceptible Staphylococcus aureus or S. pyogenes.